INS and type 1 diabetes mellitus: This is the first report of ketoacidosis after coronavirus disease-2019 vaccination.<h4>Conclusion</h4>The vaccine should be carefully administered to type 1 diabetes patients receiving intensive insulin therapy and a sodium-glucose transporter due to the high risk ketoacidosis.